Corebridge Financial’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-55,061	Closed	-$44.4K	–	546
2025 Q1	$44.4K	Sell	55,061 -254	-0.5%	-$205	﹤0.01%	2761
2024 Q4	$76.3K	Sell	55,315 -4,176	-7%	-$5.76K	﹤0.01%	2683
2024 Q3	$61.9K	Buy	59,491 +273	+0.5%	+$284	﹤0.01%	2811
2024 Q2	$102K	Buy	+59,218	New	+$102K	﹤0.01%	2591